SATIN: Satiety Innovation. Study 2- University of Aberdeen

Summary

The proposed study will address the effect of developed novel food products through processing innovation on motivation to eat, biomarkers of satiety, nutrient bioavailability and gut health using in vivo studies and validating new in vivo approaches.

Specifically in this protocol the investigators will address, in a short human intervention study the effect of a potentially satiating product on appetite, appetite biomarkers, particularly the influence on gut microbiota, tolerance and safety of the products in healthy obese and overweight participants in free living conditions.

Conditions

• Overweight and Obesity

Interventions

OTHER

Arabinoxylan

10 days of weight loss diet calculated as 100% RMR + 15g Arabinoxylan (Medium Chain Naxus, BioActor b.v., Netherlands) per day in incremental dose 25% according energy requirement, 30% protein, 30% fat, 40% carbohydrate.

OTHER

Beta- Glucan

10 days of weight loss diet calculated as 100% RMR + 6g β-glucan (Viscofibre, Naturex SA, France) per day in incremental dose 25% according energy requirement, 30% protein, 30% fat, 40%

Sponsors & Collaborators

• Københavns Universitet

  collaborator OTHER

• University of Leeds

  collaborator OTHER

• University of Liverpool

  collaborator OTHER

• Universidad de Murcia

  collaborator OTHER

• University Rovira i Virgili

  collaborator OTHER

• Karolinska Institutet

  collaborator OTHER

• Cargill

  collaborator INDUSTRY

• The Coca-Cola Company

  collaborator INDUSTRY

• Juver Alimentación S.L.U

  collaborator INDUSTRY

• Naturex, Spain

  collaborator INDUSTRY

• Axxam S.p.A.

  collaborator INDUSTRY

• BioActor

  collaborator INDUSTRY

• Centro Tecnológico Nacional Agroalimentario Extremadura

  collaborator OTHER

• Centro Tecnológico Nacional de la Conserva y Alimentación

  collaborator OTHER

• NIZO Food Research

  collaborator OTHER

• RTD Services Vienna

  collaborator OTHER

• ProDigest

  collaborator INDUSTRY

• University of Aberdeen

  lead OTHER

Principal Investigators

• Dr Alexandra M Johnstone, PhD · University of Aberdeen

Study Design

Allocation

RANDOMIZED

Purpose

BASIC_SCIENCE

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

65 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2014-01-31

Primary Completion

2016-12-31

Completion

2016-12-31

Countries

• United Kingdom

Study Locations